Open access
Open access
Powered by Google Translator Translator

Endocrinology (all articles)

USPSTF Draft Statement: Statin use for the primary prevention of cardiovascular disease in adults.

23 Feb, 2022 | 10:45h | UTC

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication – U.S. Preventive Services Task Force

Commentary: USPSTF Updates Guidance on Statins for Primary Prevention of CVD – HealthDay

 


Raw and cooked vegetable consumption and risk of cardiovascular disease: a study of 400,000 adults in UK Biobank.

22 Feb, 2022 | 09:51h | UTC

Raw and Cooked Vegetable Consumption and Risk of Cardiovascular Disease: A Study of 400,000 Adults in UK Biobank – Frontiers in Nutrition

Commentaries:

Eating veggies won’t protect your heart, study says, but critics disagree – CNN

Study Finds No Heart Benefit From Veggies. Nutritionists Disagree – HealthDay

Eating vegetables does not protect against cardiovascular disease, finds large-scale study – Frontiers

 


Position Statement: a disease state approach to the pharmacological management of type 2 diabetes in primary care.

22 Feb, 2022 | 08:51h | UTC

2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care

Related:

NICE Updated Guidance: Management of Type 2 Diabetes.

Guideline: ADA 2022 Standards of Medical Care in Diabetes.

 


M-A of randomized trials | Association between intensity of LDL cholesterol reduction with statin-based therapies and secondary stroke prevention.

22 Feb, 2022 | 08:37h | UTC

Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention: A Meta-analysis of Randomized Clinical Trials – JAMA Neurology

Editorial: Low-Density Lipoprotein Cholesterol Level After a Stroke—Reducing It by Any Means (free for a limited period)

 


Study suggests banning the promotion of soft drinks could be more effective than a sugar tax.

22 Feb, 2022 | 08:25h | UTC

Banning the promotion of soft drinks could be more effective than a sugar tax – The Conversation

Original Study: Industry levy versus banning promotion on soft drinks in Scotland: A distributional analysis – Food Policy

Related:

Association of a sweetened beverage tax with reduction in soda consumption in high school students.

Changes in food purchases after the Chilean policies on food labelling, marketing, and sales in schools: a before and after study.

UK National Food Strategy: Tax sugar and salt and prescribe veg, report says.

Perspective – Sugar-sweetened beverage taxes: Lessons to date and the future of taxation

Cohort Study: Association Between Tax on Sugar Sweetened Beverages and Soft Drink Consumption

Meta-Analysis: Impact of Sugar‐sweetened Beverage Taxes on Purchases and Dietary Intake

Cochrane Review: Environmental Interventions to Reduce the Consumption of Sugar‐sweetened Beverages and Their Effects on Health

Study: Snack Tax May be More Effective than a Sugary Drink Tax to Tackle Obesity

Sugar Tax: Why Health Experts Want it But Politicians and Industry are Resisting

The Effect of Food Price Changes on Consumer Purchases: A Randomized Experiment

Taxes on Sugar-Sweetened Beverages Associated with Reduced Consumption

Soda Tax Linked to a 50 Percent Reduction in Sugary Drink Consumption

AAP/AHA Policy Statement: Public Policies to Reduce Sugary Drink Consumption in Children and Adolescents

Fiscal policies for diet and the prevention of noncommunicable diseases – World Health Organization

The Lancet taskforce on NCDs and economics

To improve global health, tax the things that are killing us – Financial Times

Reducing cardiovascular disease burden through targeted dietary policies

Fiscal policies for the prevention of diseases

The potential impact of food taxes and subsidies on cardiovascular disease and diabetes burden and disparities

 


Personal View | Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridemia.

22 Feb, 2022 | 08:17h | UTC

Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia – The Lancet Diabetes & Endocrinology (free for a limited period)

 


Dietary carbohydrate and the risk of type 2 diabetes: an updated systematic review and dose–response meta-analysis of prospective cohort studies.

22 Feb, 2022 | 08:16h | UTC

Dietary carbohydrate and the risk of type 2 diabetes: an updated systematic review and dose–response meta-analysis of prospective cohort studies – Scientific Reports

 


RCT: Advising overweight patients to increase sleep duration may reduce caloric intake.

21 Feb, 2022 | 09:27h | UTC

Effect of Sleep Extension on Objectively Assessed Energy Intake Among Adults With Overweight in Real-life Settings: A Randomized Clinical Trial – JAMA Internal Medicine

News Release: Getting more sleep reduces caloric intake, a game changer for weight loss programs – University of Chicago Medical Center

Commentaries:

Cut nearly 300 calories a day by doing something you already do – CNN

Individualized Sleep Counseling Can Aid Weight Loss in Overweight – HealthDay

 

Commentary on Twitter

 


Expert Review | The importance of nutrition in pregnancy and lactation: lifelong consequences.

21 Feb, 2022 | 08:38h | UTC

The importance of nutrition in pregnancy and lactation: lifelong consequences – The American Journal of Obstetrics & Gynecology

 


NICE Updated Guidance: Management of Type 2 Diabetes.

18 Feb, 2022 | 08:41h | UTC

Type 2 diabetes in adults: management – National Institute for Health and Care Excellence

Related: Guideline: ADA 2022 Standards of Medical Care in Diabetes.

 


Cohort Study: Osteoporosis and its association with cardiovascular disease, respiratory disease, and cancer.

18 Feb, 2022 | 08:24h | UTC

Osteoporosis and Its Association With Cardiovascular Disease, Respiratory Disease, and Cancer: Findings From the UK Biobank Prospective Cohort Study – Mayo Clinic Proceedings (link to abstract – $ for full-text)

 


Meta-analysis finds the overall prevalence of statin intolerance is around 9% and identifies the most common risk factors.

17 Feb, 2022 | 10:07h | UTC

Prevalence of statin intolerance: a meta-analysis – European Heart Journal

Commentaries:

Study shows the true prevalence of statin intolerance worldwide is between 6 to 10% – News Medical / European Society of Cardiology

Expert reaction to study looking at statin intolerance – Science Media Centre

Related:

Side effect patterns in a crossover trial of statin, placebo, and no treatment – This N-of-1 trial, now published in full, suggests the nocebo effect causes most of statins muscle adverse effects.

#AHA20 – In patients who had discontinued statins because of side effects, a N-of-1 trial of a statin, placebo, or no treatment found that side effects often attributed to statins were the same for those taking a placebo

 

Commentary on Twitter

 


A novel diabetes typology: towards precision diabetology from pathogenesis to treatment.

17 Feb, 2022 | 08:31h | UTC

A novel diabetes typology: towards precision diabetology from pathogenesis to treatment – Diabetologia

 


RCT: Effects of a 6-month, low-carbohydrate diet on glycemic control, body composition, and cardiovascular risk factors in patients with type 2 diabetes.

13 Feb, 2022 | 22:35h | UTC

Effects of a 6-month, low-carbohydrate diet on glycaemic control, body composition, and cardiovascular risk factors in patients with type 2 diabetes: An open-label randomized controlled trial – Diabetes, Obesity and Metabolism

 


FIMS / EFSMA Joint position statement on the International Olympic Committee framework on fairness, inclusion and non-discrimination based on gender identity and sex variations.

13 Feb, 2022 | 22:17h | UTC

Joint position statement of the International Federation of Sports Medicine (FIMS) and European Federation of Sports Medicine Associations (EFSMA) on the IOC framework on fairness, inclusion and non-discrimination based on gender identity and sex variations – BMJ Open Sport & Exercise Medicine

Original Guidance: IOC Framework on fairness, inclusion and non-discrimination on the basis of gender identity and sex variations – International Olympic Committee

Commentary: International Olympic Committee transgender guidance criticised by medical experts – BBC

 

Commentary on Twitter

 


Review: Global accessibility of therapeutics for diabetes mellitus.

13 Feb, 2022 | 21:51h | UTC

Global accessibility of therapeutics for diabetes mellitus – Nature Reviews Endocrinology (if the link is paywalled, try this one)

Related:

New WHO report maps barriers to insulin availability and suggests actions to promote universal access – “100 years after its discovery, insulin still out of reach for many living with diabetes”.

Editorial | Insulin for all: a hope yet to be realized.

One hundred years of insulin therapy.

The state of diabetes treatment coverage in 55 low-income and middle-income countries – fewer than one in ten people with diabetes in LMICs receive comprehensive care such as low-cost medicines to reduce blood sugar, blood pressure and cholesterol levels, in addition to counseling on diet, exercise and weight.

 


Guideline for the management of pediatric Graves’ disease.

11 Feb, 2022 | 08:24h | UTC

2022 European Thyroid Association Guideline for the management of pediatric Graves’ disease – European Thyroid Journal

 


RCT: Subcutaneous Tirzepatide added to titrated Insulin Glargine improves glycemic control in patients with Type 2 Diabetes.

10 Feb, 2022 | 10:00h | UTC

Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Tirzepatide for Patients With Type 2 Diabetes – JAMA

Commentary: SURPASS-5 Data: Tirzepatide Plus Insulin Glargine Improve Glycemic Control in T2D – AJMC

Related:

RCT: In patients with Type 2 Diabetes, Tirzepatide is associated with reduced weight, improved glycemic control, and lower risk of hypoglycemia compared to insulin glargine.

RCT: Once-weekly tirzepatide vs. once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes.

RCT: Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2.

RCT: Tirzepatide yielded greater glycated hemoglobin and body weight reductions compared to Semaglutide 1 mg.

 


Position statement on the care of the athlete and athletic person with diabetes.

10 Feb, 2022 | 08:49h | UTC

American Medical Society for Sports Medicine Position Statement on the Care of the Athlete and Athletic Person With Diabetes – Clinical Journal of Sport Medicine

 


Podcast: Dyslipidemia in Children.

8 Feb, 2022 | 08:33h | UTC

#41: The Good, the Bad, and the Fasting: Dyslipidemia with Dr. Stephen Daniels – The Cribsiders Pediatric Medicine

 


Guideline: Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease.

4 Feb, 2022 | 08:49h | UTC

Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021 – BMC Nephrology

 


Cross-sectional analysis: increased visceral adipose tissue in adults linked to reduced cognitive scores.

3 Feb, 2022 | 08:41h | UTC

Evaluation of Adiposity and Cognitive Function in Adults – JAMA Network Open

Commentaries:

Excess Body Fat Tied to Lower Cognitive Scores in Adults – HealthDay

Expert reaction to study looking at the association between body fat and cognition in adults – Science Media Centre

 

Commentary on Twitter

 


Review: Diagnosis and treatment of acromegaly.

3 Feb, 2022 | 08:34h | UTC

Diagnosis and Treatment of Acromegaly: An Update – Mayo Clinic Proceedings

 


Review: Prevention of atherosclerosis from childhood.

2 Feb, 2022 | 08:12h | UTC

Prevention of atherosclerosis from childhood – Nature Reviews Cardiology (if the link is paywalled, try this one)

 


Review: Primary care-based cardiovascular disease risk management after adverse pregnancy outcomes.

1 Feb, 2022 | 08:29h | UTC

Primary Care–Based Cardiovascular Disease Risk Management After Adverse Pregnancy Outcomes: a Narrative Review – Journal of General Internal Medicine (if the link is paywalled, try this one)

Commentary: Better management of long-term heart disease risk needed following complicated pregnancies – Boston Medical Center

See also: thread from the author on Twitter summarizing the article

Related:

A national cohort study in Sweden showed pregnancy complications (preeclampsia or eclampsia, gestational hypertension, gestational diabetes, preterm birth, small for gestational age, and stillbirth) are associated with increased risk of cardiovascular disease later in life.

AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk

Consensus statement: Cardiovascular health after menopause transition, pregnancy disorders, and other gynecologic conditions

Cohort Study: Preeclampsia and Cardiovascular Disease

Cohort Study: Cardiovascular Disease After Hypertensive Disorders of Pregnancy Largely Explained by Conventional Cardiovascular Risk Factors (recent studies on the subject)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.